Role of β3 subunit of the GABA type A receptor in triple negative breast cancer proliferation, migration, and cell cycle progression

References

• Breast Cancer Research Foundation. 2021. Breast Cancer Statistics and Resources: Breast Cancer Research Foundation: BCRF. [cited 2023 April 8]; Available from: https://www.bcrf.org/breast-cancer-statistics-and-resources/
   Google Scholar
• Dobruch-Sobczak K, Gumowska M, Mączewska J, et al. Immunohistochemical subtypes of the breast cancer in the ultrasound and clinical aspect – literature review. J Ultrason. 2022;22(89):93–99. doi: 10.15557/JoU.2022.0016
   PubMed Web of Science ®Google Scholar
• Lu B, Natarajan E, Balaji Raghavendran HR, et al. Molecular classification, treatment, and genetic biomarkers in triple-negative breast cancer: a review. Technol Cancer Res Treat. 2023;22:15330338221145246. doi: 10.1177/15330338221145246
   Web of Science ®Google Scholar
• Bianchini G, Balko JM, Mayer IA, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13(11):674–690. doi: 10.1038/nrclinonc.2016.66
   PubMed Web of Science ®Google Scholar
• Capatina AL, Lagos D, Brackenbury WJ. Targeting ion channels for cancer treatment: current progress and future challenges. Rev Physiol Biochem Pharmacol. 2022;183:1–43.
   PubMedGoogle Scholar
• Rao VR, Perez-Neut M, Kaja S, et al. Voltage-gated ion channels in cancer cell proliferation. Cancers (Basel). 2015;7(2):849–875. doi: 10.3390/cancers7020813
   PubMed Web of Science ®Google Scholar
• Angus M, Ruben P. Voltage gated sodium channels in cancer and their potential mechanisms of action. Channels (Austin). 2019;13(1):400–409. doi: 10.1080/19336950.2019.1666455
   PubMed Web of Science ®Google Scholar
• Chiliquinga AJ, Acosta B, Ogonaga-Borja I, et al. Ion channels as potential tools for the diagnosis, prognosis, and treatment of HPV-Associated cancers. Cells. 2023;12(10):1376. doi: 10.3390/cells12101376
   PubMed Web of Science ®Google Scholar
• Hong S, BI M, Wang L, et al. CLC-3 channels in cancer (review). Oncol Rep. 2015;33(2):507–514. doi: 10.3892/or.2014.3615
   PubMed Web of Science ®Google Scholar
• Ong J, Kerr DI. GABA-receptors in peripheral tissues. Life Sci. 1990;46(21):1489–1501. doi: 10.1016/0024-3205(90)90421-M
   PubMed Web of Science ®Google Scholar
• Becchetti A. Ion channels and transporters in cancer. 1. Ion channels and cell proliferation in cancer. Am J Physiol Cell Physiol. 2011;301(2):C255–65. doi: 10.1152/ajpcell.00047.2011
   PubMed Web of Science ®Google Scholar
• Jayachandran P, Battaglin F, Strelez C, et al. Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions. Oncogene. 2023;42(9):627–637. doi: 10.1038/s41388-022-02584-4
   PubMed Web of Science ®Google Scholar
• Huang D, Alexander PB, Li Q-J, et al. GABAergic signaling beyond synapses: an emerging target for cancer therapy. Trends Cell Biol. 2022;33(5):403–412. doi: 10.1016/j.tcb.2022.08.004
   PubMed Web of Science ®Google Scholar
• Huang D, Alexander PB, Li Q-J, et al. GABAergic signaling beyond synapses: an emerging target for cancer therapy. Trends Cell Biol. 2023;33(5):403–412. doi: 10.1016/j.tcb.2022.08.004
   PubMed Web of Science ®Google Scholar
• Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function update. Pharmacol Rev. 2008;60(3):243–260. doi: 10.1124/pr.108.00505
   PubMed Web of Science ®Google Scholar
• Olsen RW, Sieghart W. GABA a receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009;56(1):141–148. doi: 10.1016/j.neuropharm.2008.07.045
   PubMed Web of Science ®Google Scholar
• Nguyen QA, Nicoll RA. The GABA(A) receptor beta subunit is required for inhibitory transmission. Neuron. 2018;98(4):718–725 e3. doi: 10.1016/j.neuron.2018.03.046
   PubMed Web of Science ®Google Scholar
• Abdul M, McCray SD, Hoosein NM. Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer. Acta Oncol. 2008;47(8):1546–1550. doi: 10.1080/02841860801961265
   PubMed Web of Science ®Google Scholar
• Jiang SH, Zhu L-L, Zhang M, et al. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca 2+ signalling in a GABA-independent manner. Gut. 2019;68(11):1994–2006. doi: 10.1136/gutjnl-2018-317479
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Li A, Kossenkov AV, et al. The mRNA-edited form of GABRA3 suppresses GABRA3-mediated akt activation and breast cancer metastasis. Nat Commun. 2016;7(1):10715. doi: 10.1038/ncomms10715
   PubMedGoogle Scholar
• Sizemore GM, Sizemore ST, Seachrist DD, et al. GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2). J Biol Chem. 2014;289(35):24102–24113. doi: 10.1074/jbc.M114.593582
   PubMed Web of Science ®Google Scholar
• Li N, Xu X, Liu D, et al. The delta subunit of the GABA a receptor is necessary for the GPT2-promoted breast cancer metastasis. Theranostics. 2023;13(4):1355–1369. doi: 10.7150/thno.80544
   PubMed Web of Science ®Google Scholar
• Tarradas A, Selga E, Beltran-Alvarez P, et al. A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome. PLoS One. 2013;8(1):e53220. doi: 10.1371/journal.pone.0053220
   PubMed Web of Science ®Google Scholar
• Azuma H, Inamoto T, Sakamoto T, et al. Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. Cancer Res. 2003;63(23):8090–8096.
   PubMed Web of Science ®Google Scholar
• Maemura K, Shiraishi N, Sakagami K, et al. Proliferative effects of γ-aminobutyric acid on the gastric cancer cell line are associated with extracellular signal-regulated kinase 1/2 activation. J Gastro Hepatol. 2009;24(4):688–696. doi: 10.1111/j.1440-1746.2008.05687.x
   PubMed Web of Science ®Google Scholar
• McCartney MR, Deeb TZ, Henderson TN, et al. Tonically active GABAA receptors in hippocampal pyramidal neurons exhibit constitutive GABA-independent gating. Mol Pharmacol. 2007;71(2):539–548. doi: 10.1124/mol.106.028597
   PubMed Web of Science ®Google Scholar
• Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–2767. doi: 10.1172/JCI45014
   PubMed Web of Science ®Google Scholar
• Soule HD, Maloney TM, Wolman SR, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990;50(18):6075–6086.
   PubMed Web of Science ®Google Scholar
• Puleo J, Polyak K. The MCF10 model of breast tumor progression. Cancer Res. 2021;81(16):4183–4185. doi: 10.1158/0008-5472.CAN-21-1939
   PubMed Web of Science ®Google Scholar
• Johnston GA. Muscimol as an ionotropic GABA receptor agonist. Neurochem Res. 2014;39(10):1942–1947. doi: 10.1007/s11064-014-1245-y
   PubMed Web of Science ®Google Scholar
• Johnston GA. Advantages of an antagonist: bicuculline and other GABA antagonists. Br J Pharmacol. 2013;169(2):328–336. doi: 10.1111/bph.12127
   PubMed Web of Science ®Google Scholar
• Huang SH, Duke RK, Chebib M, et al. Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant α1β2γ2L GABAA receptors. Eur J Pharmacol. 2003;464(1):1–8. doi: 10.1016/S0014-2999(03)01344-X
   PubMed Web of Science ®Google Scholar
• Fiszer De Plazas S. Ontogenesis of GABA receptor sites in chick embryo cerebellum. Brain Res. 1982;255(2):263–275. doi: 10.1016/0165-3806(82)90026-8
   PubMedGoogle Scholar
• Zhang D, Li X, Yao Z, et al. GABAergic signaling facilitates breast cancer metastasis by promoting ERK1/2-dependent phosphorylation. Cancer Lett. 2014;348(1–2):100–108. doi: 10.1016/j.canlet.2014.03.006
   PubMed Web of Science ®Google Scholar
• Bieche I, Olivi M, Noguès C, et al. Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays. Br J Cancer. 2002;86(4):580–586. doi: 10.1038/sj.bjc.6600109
   PubMed Web of Science ®Google Scholar
• Drobnjak M, Osman I, Scher HI, et al. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res. 2000;6(5):1891–1895.
   PubMed Web of Science ®Google Scholar
• Dai M, Al-Odaini AA, Fils-Aimé N, et al. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res. 2013;15(3):R49. doi: 10.1186/bcr3441
   PubMed Web of Science ®Google Scholar
• Bertoli C, Skotheim JM, de Bruin RA. Control of cell cycle transcription during G1 and S phases. Nat Rev Mol Cell Biol. 2013;14(8):518–528. doi: 10.1038/nrm3629
   PubMed Web of Science ®Google Scholar
• Beykou M, Arias-Garcia M, Roumeliotis TI, et al. Proteomic characterisation of triple negative breast cancer cells following CDK4/6 inhibition. Sci Data. 2022;9(1):395. doi: 10.1038/s41597-022-01512-1
   PubMed Web of Science ®Google Scholar
• Olsen RW. GABA(A) receptor: Positive and negative allosteric modulators. Neuropharmacology. 2018;136(Pt A):10–22. doi: 10.1016/j.neuropharm.2018.01.036
   PubMed Web of Science ®Google Scholar
• Shamloo B, Usluer S. p21 in cancer research. Cancers (Basel). 2019;11(8):1178. doi: 10.3390/cancers11081178
   PubMed Web of Science ®Google Scholar
• Ibnat N, Kamaruzman NI, Ashaie M, et al. Transfection with p21 and p53 tumor suppressor plasmids suppressed breast tumor growth in syngeneic mouse model. Gene. 2019;701:32–40. doi: 10.1016/j.gene.2019.02.082
   PubMed Web of Science ®Google Scholar
• Kallay L, Keskin H, Ross A, et al. Modulating native GABA(A) receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death. J Neurooncol. 2019;142(3):411–422. doi: 10.1007/s11060-019-03115-0
   PubMed Web of Science ®Google Scholar
• Shiozaki A, Otsuji E, Marunaka Y. Intracellular chloride regulates the G(1)/S cell cycle progression in gastric cancer cells. World J Gastrointest Oncol. 2011;3(8):119–122. doi: 10.4251/wjgo.v3.i8.119
   PubMed Web of Science ®Google Scholar
• Hiraoka K, Miyazaki H, Niisato N, et al. Chloride ion modulates cell proliferation of human androgen-independent prostatic cancer cell. Cell Physiol Biochem. 2010;25(4–5):379–388. doi: 10.1159/000303042
   PubMedGoogle Scholar
• Maki M, Miyazaki H, Nakajima K-I, et al. Chloride-dependent acceleration of cell cycle via modulation of Rb and cdc2 in osteoblastic cells. Biochem Biophys Res Commun. 2007;361(4):1038–1043. doi: 10.1016/j.bbrc.2007.07.131
   PubMed Web of Science ®Google Scholar
• Montalto FI, De Amicis F. Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma. Cells. 2020;9(12):2648. doi: 10.3390/cells9122648
   PubMed Web of Science ®Google Scholar
• Wlodarczyk AI, Sylantyev S, Herd MB, et al. GABA-independent GABAA receptor openings maintain tonic currents. J Neurosci. 2013;33(9):3905–3914. doi: 10.1523/JNEUROSCI.4193-12.2013
   PubMed Web of Science ®Google Scholar